Healthy Clinical Trial
Official title:
The Effects of Immobilisation and Exercise on Homeostatic Plasticity Mechanisms in Healthy Participants
| Verified date | February 2023 |
| Source | Aalborg University |
| Contact | n/a |
| Is FDA regulated | No |
| Health authority | |
| Study type | Interventional |
Homeostasis is important for maintaining a stable equilibrium of e.g., blood pressure, hormonal release, and release of neurotransmitters. Within the healthy brain, homeostatic plasticity mechanisms ensure stability in synaptic plasticity that maintains cortical excitability within a normal physiological range, while this regulation has been shown to be impaired in chronic pain conditions such as low back pain. Cortical excitability can also be decreased and increased experimentally, using immobilisation and exercise paradigms, respectively, yet it is unknown if this overall change in excitability is caused by a shift in homeostatic plasticity regulation. Investigating if immobilisation and exercise influences homeostatic plasticity responses, may therefore reveal important information on the malleability of homeostatic plasticity mechanisms and ways to modulate them.
| Status | Completed |
| Enrollment | 11 |
| Est. completion date | December 31, 2022 |
| Est. primary completion date | December 31, 2022 |
| Accepts healthy volunteers | Accepts Healthy Volunteers |
| Gender | All |
| Age group | 18 Years to 60 Years |
| Eligibility | Inclusion Criteria: o Healthy, aged between 18-60 years, right-handed, and can speak, read, and understand Danish or English Exclusion Criteria: - Pregnant or breastfeeding - Regular use of cannabis, opioids or other drugs (except contraceptives) - Current or previous neurologic, musculoskeletal, mental, or other illnesses (e.g. brain or spinal cord injuries, degenerative neurological disorders, epilepsy, major depression, cardiovascular disease, chronic lung disease, etc.) - Current or previous chronic or recurrent pain condition - Current regular use of analgesic medication or other medication which may affect the trial (including paracetamol and NSAIDs) - Lack of ability to cooperate - Recent history of acute pain particularly in the lower limbs (unless related to low back pain in patients included in sub-project 6) - Abnormally disrupted sleep in 24 hours preceding experiment - Any medical or other condition (i.e. musculoskeletal, cardiorespiratory, neurological, etc.) - Contraindications to TMS application (history of epilepsy, metal implants in head or jaw, etc.) - Unable to pass the "Transcranial Magnetic Stimulation Adult Safety Screen" or tDCS screening questionnaire |
| Country | Name | City | State |
|---|---|---|---|
| Denmark | Aalborg University | Aalborg | Nordjylland |
| Lead Sponsor | Collaborator |
|---|---|
| Aalborg University |
Denmark,
Fricke K, Seeber AA, Thirugnanasambandam N, Paulus W, Nitsche MA, Rothwell JC. Time course of the induction of homeostatic plasticity generated by repeated transcranial direct current stimulation of the human motor cortex. J Neurophysiol. 2011 Mar;105(3):1141-9. doi: 10.1152/jn.00608.2009. Epub 2010 Dec 22. — View Citation
Thapa T, Graven-Nielsen T, Chipchase LS, Schabrun SM. Disruption of cortical synaptic homeostasis in individuals with chronic low back pain. Clin Neurophysiol. 2018 May;129(5):1090-1096. doi: 10.1016/j.clinph.2018.01.060. Epub 2018 Feb 9. — View Citation
Thapa T, Graven-Nielsen T, Schabrun SM. Aberrant plasticity in musculoskeletal pain: a failure of homeostatic control? Exp Brain Res. 2021 Apr;239(4):1317-1326. doi: 10.1007/s00221-021-06062-3. Epub 2021 Feb 26. — View Citation
Wittkopf PG, Larsen DB, Gregoret L, Graven-Nielsen T. Prolonged corticomotor homeostatic plasticity - Effects of different protocols and their reliability. Brain Stimul. 2021 Mar-Apr;14(2):327-329. doi: 10.1016/j.brs.2021.01.017. Epub 2021 Jan 24. No abstract available. — View Citation
| Type | Measure | Description | Time frame | Safety issue |
|---|---|---|---|---|
| Primary | Corticospinal excitability | Change in corticospinal excitability (compared to baseline), as reflected by motor-evoked potential amplitudes induced by transcranial magnetic stimulation, after homeostatic plasticity induction | Immediately after [0 minutes after homeostatic plasticity induction] and every 10 minutes up until 30 minutes after [10-30 minutes after homeostatic plasticity induction] | |
| Secondary | Quantitative Sensory Testing: Cuff detection threshold | Cuff detection threshold [kPa] | Before and 30 minutes post homeostatic plasticity induction | |
| Secondary | Quantitative Sensory Testing: Cuff pain tolerance threshold | Cuff pain tolerance threshold [kPa] | Before and 30 minutes post homeostatic plasticity induction | |
| Secondary | Quantitative Sensory Testing: Conditioned pain modulation | Conditioned pain modulation [kPa change] | Before and 30 minutes post homeostatic plasticity induction | |
| Secondary | Quantitative Sensory Testing: Temporal summation of pain | Temporal summation of pain [pain rating; Visual analogue scale; 0-10 cm; higher scores means more pain] | Before and 30 minutes post homeostatic plasticity induction | |
| Secondary | Quantitative Sensory Testing: Mechanical pain threshold | Mechanical pain threshold (pin prick) [force required for inducing pricking pain; nM] | Before and 30 minutes post homeostatic plasticity induction | |
| Secondary | Quantitative Sensory Testing: Handheld algometry at right dorsal interosseous muscle | Handheld algometry at right dorsal interosseous muscle [kPa] | Before and 30 minutes post homeostatic plasticity induction | |
| Secondary | Quantitative Sensory Testing: Handheld algometry at left dorsal interosseous muscle | Handheld algometry at left dorsal interosseous muscle [kPa] | Before and 30 minutes post homeostatic plasticity induction | |
| Secondary | Quantitative Sensory Testing: Handheld algometry at right tibialis anterior muscle | Handheld algometry at right tibialis anterior muscle [kPa] | Before and 30 minutes post homeostatic plasticity induction | |
| Secondary | Questionnaires: Pittsburgh Sleep Quality Index | Pittsburgh Sleep Quality Index (PSQI; 0-21; PSQI > 5 means poor sleep quality) | Before baseline corticospinal excitability measurements | |
| Secondary | Questionnaires: Pain Catastrophizing Scale | Pain Catastrophizing Scale (PCS; 0-52; higher score means more pain catastrophizing) | Before baseline corticospinal excitability measurements | |
| Secondary | Questionnaires: International Physical Activity Questionnaire | International Physical Activity Questionnaire (IPAQ; resting metabolic rate multiplied by activity per minutes performed > higher means better physical activity) | Before baseline corticospinal excitability measurements | |
| Secondary | Questionnaires: Positive and Negative Affective Schedule | Positive and Negative Affective Schedule - Short Form (PANAS; 10-50; higher scores = higher levels of negative or positive affect) | Before baseline corticospinal excitability measurements |
| Status | Clinical Trial | Phase | |
|---|---|---|---|
| Recruiting |
NCT06052553 -
A Study of TopSpin360 Training Device
|
N/A | |
| Completed |
NCT05511077 -
Biomarkers of Oat Product Intake: The BiOAT Marker Study
|
N/A | |
| Recruiting |
NCT04632485 -
Early Detection of Vascular Dysfunction Using Biomarkers From Lagrangian Carotid Strain Imaging
|
||
| Completed |
NCT05931237 -
Cranberry Flavan-3-ols Consumption and Gut Microbiota in Healthy Adults
|
N/A | |
| Terminated |
NCT04556032 -
Effects of Ergothioneine on Cognition, Mood, and Sleep in Healthy Adult Men and Women
|
N/A | |
| Completed |
NCT04527718 -
Study of the Safety, Tolerability and Pharmacokinetics of 611 in Adult Healthy Volunteers
|
Phase 1 | |
| Completed |
NCT04065295 -
A Study to Test How Well Healthy Men Tolerate Different Doses of BI 1356225
|
Phase 1 | |
| Completed |
NCT04998695 -
Health Effects of Consuming Olive Pomace Oil
|
N/A | |
| Completed |
NCT04107441 -
AX-8 Drug Safety, Tolerability and Plasma Levels in Healthy Subjects
|
Phase 1 | |
| Completed |
NCT01442831 -
Evaluate the Absorption, Metabolism, And Excretion Of Orally Administered [14C] TR 701 In Healthy Adult Male Subjects
|
Phase 1 | |
| Terminated |
NCT05934942 -
A Study in Healthy Women to Test Whether BI 1358894 Influences the Amount of a Contraceptive in the Blood
|
Phase 1 | |
| Recruiting |
NCT05525845 -
Studying the Hedonic and Homeostatic Regulation of Food Intake Using Functional MRI
|
N/A | |
| Completed |
NCT05515328 -
A Study in Healthy Men to Test How BI 685509 is Processed in the Body
|
Phase 1 | |
| Completed |
NCT04967157 -
Cognitive Effects of Citicoline on Attention in Healthy Men and Women
|
N/A | |
| Completed |
NCT05030857 -
Drug-drug Interaction and Food-effect Study With GLPG4716 and Midazolam in Healthy Subjects
|
Phase 1 | |
| Recruiting |
NCT04714294 -
Evaluate the Safety, Tolerability and Pharmacokinetics Characteristics of HPP737 in Healthy Volunteers
|
Phase 1 | |
| Recruiting |
NCT04494269 -
A Study to Evaluate Pharmacokinetics and Safety of Tegoprazan in Subjects With Hepatic Impairment and Healthy Controls
|
Phase 1 | |
| Completed |
NCT04539756 -
Writing Activities and Emotions
|
N/A | |
| Recruiting |
NCT04098510 -
Concentration of MitoQ in Human Skeletal Muscle
|
N/A | |
| Completed |
NCT03308110 -
Bioavailability and Food Effect Study of Two Formulations of PF-06650833
|
Phase 1 |